Zephyrnet Logo

Somavedic reports positive data from ABE and EEMT trial

Date:

<!–

–>

Somavedic and BrainTap have reported positive data from a pilot study of Audio Brainwave Entrainment (ABE) and electromagnetic field (EMF) effects mitigation technology (EEMT).

The six-week trial included 20 subjects aged 34 to 65 years who underwent two daily BrainTap sessions, which involved using a BrainTap headset near a Somavedic device.

According to the findings, participants had a statistically significant improvement in their sleep and mood quality, as well as a reduction in stress and depressive mood, after the ABE and EEMT introduction.

All participants also experienced more restful sleep, while 90% of them had an improvement in their happiness and overall disposition.

The Profile of Mood States (POMS) questionnaire, Pittsburgh Quality of Sleep Index, and The Depression, Anxiety and Stress Scale (DASS-21) assessments were used to evaluate the results and effectiveness.

Somavedic noted that the study participants did not use analgesics, anti-inflammatories or sleep aids for at least seven days before, as well as throughout, the study.

The company expects that the trial will encourage more extensive use of ABE and EEMT to improve overall well-being.

BrainTap scientific officer Dr Francisco Cidral said: “As a researcher, I was pleased to see that the results of the study will allow us to positively recommend our users to combine the BrainTap and Somavedic technologies to improve sleep, mood, stress and depression.

“Overall results indicate positive effects of Audio Brainwave Entrainment and EMF effects mitigation technology.”

Somavedic stated that the pilot trial could significantly impact the future of brain fitness as well as frequency therapy technology.

It is also expected to provide new possibilities for people looking for improving their health and well-being.

<!– GPT AdSlot 3 for Ad unit 'Verdict/Verdict_In_Article' ### Size: [[670,220]] —

googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-8581390-1’); });

!– End AdSlot 3 –>

spot_img

Latest Intelligence

spot_img